Charles Schwab Investment Management »

Forte Biosciences shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1000k 47k 21.25

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Forte Biosciences

Federated Investors
OrbiMed Advisors
Fred Alger Management
Jupiter Topco
BlackRock
Henderson Group
Affinity Asset Advisors
MPM Oncology Impact Management
TCG Crossover Management
Vanguard Capital Management
Woodline Partners
Adage Capital Partners GP
Integral Health Asset Management
Millennium Management
Citadel Advisors

View all funds holding Forte Biosciences